SEC Form 4 · accession 0001209191-15-045416
PUMA BIOTECHNOLOGY, INC. · PBYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Paul Bryce
Officer — SR VP, CLINICAL RESEARCH & DEV
Period of report
Apr 9, 2014
Accepted (ET)
May 21, 2015 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Apr 9, 2014 | P | 2 | $87.35 | A | 2 | D | |
| COMMON STOCK | Apr 11, 2014 | P | 28 | $82.49 | A | 30 | D |
Table II — derivative securities
No Table II lines on this filing.